Ilona Paulina Foik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ilona Paulina Foik has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Bonnie J. Cuthbert
Department of Molecular Biology & Biochemistry, University of California, Irvine, Irvine, CA, USA
2 shared publications - Celia W. Goulding
Department of Molecular Biology & Biochemistry, University of California, Irvine, Irvine, CA, USA
2 shared publications - Dany J. V. Beste
University of Surrey
2 shared publications - David L. Mobley
University of California, Irvine
2 shared publications - Kalistyn H. Burley
Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, California 92697, United States
2 shared publications - Piotr Garstecki
Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
2 shared publications
Latest Publications
- Open Access
- 25 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Ciprofloxacin pre-exposure influences individual cell MIC and heteroresistance of bacteria inside microfluidic droplets
Bacterial cells in general present different phenotypes even within the monoclonal populations. Some phenotypes may offer selective advantages under antibiotic stress. In clinical practice such advantage may lead to selection of resistant phenotypes and to treatment failure. Improving treatment regimens thus requires thorough understanding of the underlying cause of developing phenotypic variations within bacterial populations exposed to antibiotics. Here, we use droplet microfluidics to study the response of individual bacterial cells. We investigate how a short-term exposure of ciprofloxacin or streptomycin at the sub-minimum inhibitory concentration levels changes the single-cell distribution of susceptibility on subsequent exposure to either of the antibiotics. We used three different concentrations of pre-exposure for each antibiotic on Escherichia coli MG1655 and followed with re-exposure of the same bacterial cells individually in microfluidic droplets. Experiments with various concentrations of re-exposure on single cells showed that pre-exposures to sub-lethal levels of ciprofloxacin can elevate the individual cell MIC and the level of heteroresistance to ciprofloxacin. Exposure to quarter and half MIC of ciprofloxacin in separate experiments increased the heteroresistance of pre-exposed cells by more than 20-fold on subsequent treatment with ciprofloxacin. Interestingly, the same ciprofloxacin pre-exposure pattern made the cells more fragile and, in some cases, decreased the individual MIC values to streptomycin. The results in our study can be very important in developing new better treatment regimen, addressing the wider problem of antibiotic resistance.
- 25 September 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessCiprofloxacin pre-exposure influences individual cell MIC and heteroresistance of bacteria inside microfluidic droplets
Bacterial cells in general present different phenotypes even within the monoclonal populations. Some phenotypes may offer selective advantages under antibiotic stress. In clinical practice such advantage may lead to selection of resistant phenotypes and to treatment failure. Improving treatment regimens thus requires thorough understanding of the underlying cause of developing phenotypic variations within bacterial populations exposed to antibiotics. Here, we use droplet microfluidics to study the response of individual bacterial cells. We investigate how a short-term exposure of ciprofloxacin or streptomycin at the sub-minimum inhibitory concentration levels changes the single-cell distribution of susceptibility on subsequent exposure to either of the antibiotics. We used three different concentrations of pre-exposure for each antibiotic on Escherichia coli MG1655 and followed with re-exposure of the same bacterial cells individually in microfluidic droplets. Experiments with various concentrations of re-exposure on single cells showed that pre-exposures to sub-lethal levels of ciprofloxacin can elevate the individual cell MIC and the level of heteroresistance to ciprofloxacin. Exposure to quarter and half MIC of ciprofloxacin in separate experiments increased the heteroresistance of pre-exposed cells by more than 20-fold on subsequent treatment with ciprofloxacin. Interestingly, the same ciprofloxacin pre-exposure pattern made the cells more fragile and, in some cases, decreased the individual MIC values to streptomycin. The results in our study can be very important in developing new better treatment regimen, addressing the wider problem of antibiotic resistance.
- Open Access
- 30 July 2025
- Published by The Royal Society in Royal Society Open Science
- Vol. 12 (7)
Bacterial strain type and TEM-1 enzyme allele impact antibiotic susceptibility distribution in monoclonal populations: a single-cell droplet approach
Bacterial populations can display different susceptibilities to antibiotics among individual cells, even though they originate from the same parent cell. This variability can lead to treatment failure and the emergence of resistant bacteria. Understanding the factors influencing this variability is crucial for developing effective antibiotic treatments. The underlying cause of variation in susceptibility distribution within bacterial populations remains unclear, necessitating the development of new tools for measurement. Here, we use a droplet microfluidic single-cell antibiotic susceptibility assay and focus on antibiotic resistance conveyed by the TEM β-lactamases family. We investigate how the catalytic activity of β-lactamase, and the genetic characteristics of the host strains affect the susceptibility distribution within bacterial populations at the single-cell level. For this purpose, we selected TEM-1 with the least catalytic activity against cefotaxime, followed by its two variants, R164S and G238S, exhibiting moderate and significant catalytic activity, respectively. The results showed that increasing the catalytic activity causes an increase in the population’s mean level of antibiotic resistance. While the type of β-lactamase influences the susceptibility distribution of the strains, this effect is independent of the catalytic activity of the strains. Besides, the genetic characteristics of the strains receiving the β-lactam resistance gene is an important factor that plays a role in the distribution of susceptibility.
- 30 July 2025
- Published by The Royal Society in Royal Society Open Science
- Vol. 12 (7)
Open AccessBacterial strain type and TEM-1 enzyme allele impact antibiotic susceptibility distribution in monoclonal populations: a single-cell droplet approach
Bacterial populations can display different susceptibilities to antibiotics among individual cells, even though they originate from the same parent cell. This variability can lead to treatment failure and the emergence of resistant bacteria. Understanding the factors influencing this variability is crucial for developing effective antibiotic treatments. The underlying cause of variation in susceptibility distribution within bacterial populations remains unclear, necessitating the development of new tools for measurement. Here, we use a droplet microfluidic single-cell antibiotic susceptibility assay and focus on antibiotic resistance conveyed by the TEM β-lactamases family. We investigate how the catalytic activity of β-lactamase, and the genetic characteristics of the host strains affect the susceptibility distribution within bacterial populations at the single-cell level. For this purpose, we selected TEM-1 with the least catalytic activity against cefotaxime, followed by its two variants, R164S and G238S, exhibiting moderate and significant catalytic activity, respectively. The results showed that increasing the catalytic activity causes an increase in the population’s mean level of antibiotic resistance. While the type of β-lactamase influences the susceptibility distribution of the strains, this effect is independent of the catalytic activity of the strains. Besides, the genetic characteristics of the strains receiving the β-lactam resistance gene is an important factor that plays a role in the distribution of susceptibility.
- Open Access
Bacteria detect neutrophils via a system that responds to hypochlorous acid and flow
Neutrophils kill bacteria by producing an array of lethal molecules, including hypochlorous acid (HOCl). The extent to which pathogens detect HOCl from neutrophils and defend themselves appropriately has not been understood. We report that the opportunistic pathogen Pseudomonas aeruginosa responds to activated neutrophils by upregulating its expression of an operon which was previously shown to be activated by fluid flow, and named the flow regulated operon (Fro). We found that fro is upregulated in a mouse infection model where neutrophil influx occurs, specifically by HOCl and not by other neutrophil defense factors including LL-37, histones, or H 2 O 2 . HOCl preferentially oxidizes methionine and cysteine residues. As the Fro operon is regulated by the anti-σ factor FroI, which contains the highest density of these residues of all anti-σ factors, this raises the possibility that FroI is an HOCl sensor. In support of this, we found that via the σ factor FroR, HOCl induces upregulation of methionine sulfoxide reductases that relieve otherwise lethal oxidative stress. These findings suggest a model in which flow transports oxidizing molecules that activate the fro operon, establishing an early warning system for P. aeruginosa that improves its survival against host immune defenses and persistence during infection. Impact statement: The opportunistic pathogen Pseudomonas aeruginosa withstands the body’s first-line of defense, neutrophils, by detecting the hypochlorous acid that these cells produce and increasing their own tolerance towards it.
Open AccessBacteria detect neutrophils via a system that responds to hypochlorous acid and flow
Neutrophils kill bacteria by producing an array of lethal molecules, including hypochlorous acid (HOCl). The extent to which pathogens detect HOCl from neutrophils and defend themselves appropriately has not been understood. We report that the opportunistic pathogen Pseudomonas aeruginosa responds to activated neutrophils by upregulating its expression of an operon which was previously shown to be activated by fluid flow, and named the flow regulated operon (Fro). We found that fro is upregulated in a mouse infection model where neutrophil influx occurs, specifically by HOCl and not by other neutrophil defense factors including LL-37, histones, or H 2 O 2 . HOCl preferentially oxidizes methionine and cysteine residues. As the Fro operon is regulated by the anti-σ factor FroI, which contains the highest density of these residues of all anti-σ factors, this raises the possibility that FroI is an HOCl sensor. In support of this, we found that via the σ factor FroR, HOCl induces upregulation of methionine sulfoxide reductases that relieve otherwise lethal oxidative stress. These findings suggest a model in which flow transports oxidizing molecules that activate the fro operon, establishing an early warning system for P. aeruginosa that improves its survival against host immune defenses and persistence during infection. Impact statement: The opportunistic pathogen Pseudomonas aeruginosa withstands the body’s first-line of defense, neutrophils, by detecting the hypochlorous acid that these cells produce and increasing their own tolerance towards it.
- 23 December 2020
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 7 (1) , 174-188
Structural and Molecular Dynamics of Mycobacterium tuberculosis Malic Enzyme, a Potential Anti-TB Drug Target
Tuberculosis (TB) is the most lethal bacterial infectious disease worldwide. It is notoriously difficult to treat, requiring a cocktail of antibiotics administered over many months. The dense, waxy outer membrane of the TB-causing agent, Mycobacterium tuberculosis (Mtb), acts as a formidable barrier against uptake of antibiotics. Subsequently, enzymes involved in maintaining the integrity of the Mtb cell wall are promising drug targets. Recently, we demonstrated that Mtb lacking malic enzyme (MEZ) has altered cell wall lipid composition and attenuated uptake by macrophages. These results suggest that MEZ contributes to lipid biosynthesis by providing reductants in the form of NAD(P)H. Here, we present the X-ray crystal structure of MEZ to 3.6 Å. We use biochemical assays to demonstrate MEZ is dimeric in solution and to evaluate the effects of pH and allosteric regulators on its kinetics and thermal stability. To assess the interactions between MEZ and its substrate malate and cofactors, Mn2+ and NAD(P)+, we ran a series of molecular dynamics (MD) simulations. First, the MD analysis corroborates our empirical observations that MEZ is unusually flexible, which persists even with the addition of substrate and cofactors. Second, the MD simulations reveal that dimeric MEZ subunits alternate between open and closed states, and that MEZ can stably bind its NAD(P)+ cofactor in multiple conformations, including an inactive, compact NAD+ form. Together the structure of MEZ and insights from its dynamics can be harnessed to inform the design of MEZ inhibitors that target Mtb and not human malic enzyme homologues.
- 23 December 2020
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 7 (1) , 174-188
Structural and Molecular Dynamics of Mycobacterium tuberculosis Malic Enzyme, a Potential Anti-TB Drug Target
Tuberculosis (TB) is the most lethal bacterial infectious disease worldwide. It is notoriously difficult to treat, requiring a cocktail of antibiotics administered over many months. The dense, waxy outer membrane of the TB-causing agent, Mycobacterium tuberculosis (Mtb), acts as a formidable barrier against uptake of antibiotics. Subsequently, enzymes involved in maintaining the integrity of the Mtb cell wall are promising drug targets. Recently, we demonstrated that Mtb lacking malic enzyme (MEZ) has altered cell wall lipid composition and attenuated uptake by macrophages. These results suggest that MEZ contributes to lipid biosynthesis by providing reductants in the form of NAD(P)H. Here, we present the X-ray crystal structure of MEZ to 3.6 Å. We use biochemical assays to demonstrate MEZ is dimeric in solution and to evaluate the effects of pH and allosteric regulators on its kinetics and thermal stability. To assess the interactions between MEZ and its substrate malate and cofactors, Mn2+ and NAD(P)+, we ran a series of molecular dynamics (MD) simulations. First, the MD analysis corroborates our empirical observations that MEZ is unusually flexible, which persists even with the addition of substrate and cofactors. Second, the MD simulations reveal that dimeric MEZ subunits alternate between open and closed states, and that MEZ can stably bind its NAD(P)+ cofactor in multiple conformations, including an inactive, compact NAD+ form. Together the structure of MEZ and insights from its dynamics can be harnessed to inform the design of MEZ inhibitors that target Mtb and not human malic enzyme homologues.
- Open Access
Structural and molecular dynamics of Mycobacterium tuberculosis malic enzyme, a potential anti-TB drug target
Tuberculosis (TB) is the most lethal bacterial infectious disease worldwide. It is notoriously difficult to treat, requiring a cocktail of antibiotics administered over many months. The dense, waxy outer membrane of the TB-causing agent, Mycobacterium tuberculosis (Mtb), acts as a formidable barrier against uptake of antibiotics. Subsequently, enzymes involved in maintaining the integrity of the Mtb cell wall are promising drug targets. Recently, we demonstrated that Mtb lacking malic enzyme (MEZ) has altered cell wall lipid composition and attenuated uptake by macrophages. These results suggest that MEZ provides the required reducing power for lipid biosynthesis. Here, we present the X-ray crystal structure of MEZ to 3.6 Å resolution and compare it with known structures of prokaryotic and eukaryotic malic enzymes. We use biochemical assays to determine its oligomeric state and to evaluate the effects of pH and allosteric regulators on its kinetics and thermal stability. To assess the interactions between MEZ and its substrate malate and cofactors, Mn 2+ and NAD(P) + , we ran a series of molecular dynamics (MD) simulations. First, the MD analysis corroborates our empirical observations that MEZ is unusually disordered, which persists even with the addition of substrate and cofactors. Second, the MD simulations reveal that MEZ subunits alternate between open and closed states and that MEZ can stably bind its NAD(P) + cofactor in multiple conformations, including an inactive, compact NAD + form. Together the structure of MEZ and insights from its dynamics can be harnessed to inform the design of MEZ inhibitors that target Mtb.
Open AccessStructural and molecular dynamics of Mycobacterium tuberculosis malic enzyme, a potential anti-TB drug target
Tuberculosis (TB) is the most lethal bacterial infectious disease worldwide. It is notoriously difficult to treat, requiring a cocktail of antibiotics administered over many months. The dense, waxy outer membrane of the TB-causing agent, Mycobacterium tuberculosis (Mtb), acts as a formidable barrier against uptake of antibiotics. Subsequently, enzymes involved in maintaining the integrity of the Mtb cell wall are promising drug targets. Recently, we demonstrated that Mtb lacking malic enzyme (MEZ) has altered cell wall lipid composition and attenuated uptake by macrophages. These results suggest that MEZ provides the required reducing power for lipid biosynthesis. Here, we present the X-ray crystal structure of MEZ to 3.6 Å resolution and compare it with known structures of prokaryotic and eukaryotic malic enzymes. We use biochemical assays to determine its oligomeric state and to evaluate the effects of pH and allosteric regulators on its kinetics and thermal stability. To assess the interactions between MEZ and its substrate malate and cofactors, Mn 2+ and NAD(P) + , we ran a series of molecular dynamics (MD) simulations. First, the MD analysis corroborates our empirical observations that MEZ is unusually disordered, which persists even with the addition of substrate and cofactors. Second, the MD simulations reveal that MEZ subunits alternate between open and closed states and that MEZ can stably bind its NAD(P) + cofactor in multiple conformations, including an inactive, compact NAD + form. Together the structure of MEZ and insights from its dynamics can be harnessed to inform the design of MEZ inhibitors that target Mtb.